Yes, companies utilizing the ticker symbol BOLD—such as Boundless Bio, Inc.—are publicly traded on major stock exchanges like the NASDAQ. Publicly listed biotechnology enterprises file regular financial reports, quarterly disclosures, and regulatory documentation with the Securities and Exchange Commission, allowing institutional and retail market participants to purchase and sell common equity shares through standard retail brokerage platforms.